Health ❯ Healthcare ❯ Clinical Trials

Phase I Trials

Drug Efficacy Vaccine Trials Patient Outcomes CAR T-cell Therapy Ovarian Cancer Trials Phase II Trials Solid Tumors Dose-Escalation Studies H5N1 Vaccine Trials Dopaminergic Neuron Transplantation PDE3/4 Inhibitors Nivolumab Randomized Controlled Trials Combination Therapy Innovative Therapies Cancer Vaccine Trials Neoadjuvant Therapy Localized Treatment Strategies AVF Surgery Metastatic Cancer Trials Kidney Cancer mRNA Vaccines Efficacy Results T Cell Therapy Thyroid Cancer Trials Safety and Efficacy Cancer Treatments Therapeutic Efficacy Cancer Therapies Dual-Target CAR T Cell Therapy AMPLIFY-201 Trial

CAR‑T Therapy Lets Highly Sensitized Patients Receive Kidney Transplants

Early reports show engineered T cells can sharply reduce transplant‑blocking antibodies, pending longer trials to confirm how long the effect lasts and how safe it is.

Personalized DNA Vaccine Shows Strong Immune Response in Early Glioblastoma Study

Low-Dose Nivolumab Injections Shrink High-Risk Oral Precancers in Early Trial

First-in-Human SynKIR-110 Shows Safe Profile and Early Activity in Solid Tumors

Phase I Intranasal H5N1 Vaccine Shows Safety and Broad Immune Response

Mayo Clinic Stem Cell Trial Shows Early Gains for Dialysis Access

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

GSK Closes $12 Billion Licensing Pact for Hengrui’s COPD Therapy and 11 Preclinical Assets